School of Medicine


Showing 21-30 of 56 Results

  • Dora Ho

    Dora Ho

    Clinical Professor, Medicine - Infectious Diseases

    Current Research and Scholarly InterestsDr. Ho did her PhD work in HSV pathogenesis and postdoctoral research in CNS gene therapy with viral vectors. She is currently the clinical chief of the Division of Infectious Diseases and Geographic Medicine. She specializes in infection complications of immunocompromised patients, such as those with cancers, solid organ transplant or bone marrow transplant.

  • Mark Holodniy

    Mark Holodniy

    Professor of Medicine (Infectious Diseases)

    Current Research and Scholarly InterestsMy research program is currently focused in three areas: 1) Translational research (viral evolution and antiviral resistance prevalence and development), 2) Clinical trials (diagnostic assay/medical device, antimicrobials and immunomodulators), and 3) Health services research focusing on public health, infectious diseases and clinical outcomes.

  • Marisa Holubar

    Marisa Holubar

    Clinical Associate Professor, Medicine - Infectious Diseases

    BioDr. Marisa Holubar specializes in the treatment of infectious diseases and works primarily in the inpatient setting. She is particularly interested in antimicrobial stewardship.

  • Prasanna Jagannathan

    Prasanna Jagannathan

    Assistant Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology

    BioI am an Infectious Diseases physician-scientist with a research program in human immunology of malaria and clinical trials of immune modulatory interventions. Our group has been conducting detailed longitudinal cohort studies in children and pregnant women in order to study how repeated malaria shapes the cellular immune response. We are also studying how malaria control interventions such as antimalarial chemoprevention and vector control shape the acquisition and/or maintenance of protective immunity to malaria. We have expanded this work to not only include studying the mechanisms driving naturally acquired immunity to malaria, but other infectious diseases, including SARS CoV-2. We have also lead and/or participated in studies evaluating therapeutic strategies for patients with mild to moderate COVID-19.

  • Shanthi Kappagoda

    Shanthi Kappagoda

    Clinical Associate Professor, Medicine - Infectious Diseases

    Current Research and Scholarly InterestsCompleted a Masters degree in Health Services Research in 2012. Research focused on using network models to develop a clinical research agenda for neglected tropical diseases.

  • Michael Kozal

    Michael Kozal

    Senior Associate Dean for Veterans Affairs and Professor of Medicine (Infectious Diseases)

    BioDr. Kozal was appointed Senior Associate Dean for Veteran Affairs at Stanford School of Medicine and Chief of Staff at VA Palo Alto Health Care System in 2021. Prior to coming to Stanford, he served as Associate Dean for Veteran Affairs at Yale University School of Medicine and the Chief of Staff at VA Connecticut Healthcare System.

    Dr. Kozal is a translational researcher who has focused his research career on three areas: 1) investigating the genetic determinants of HIV and HCV drug resistance, 2) the development of new molecular methods to detect viral mutations, and 3) HIV and HCV clinical trials involving new drugs and diagnostic technology. Dr. Kozal is an expert in microarray and deep sequencing technology receiving patents for his work in genotyping. Dr. Kozal previously directed the Yale HIV Clinical Trials Group and has more than 20 years of experience in running clinical trials, serving as the principal investigator or site investigator on >40 HIV and Hepatitis C trials. He has served on multiple VA and NIH/NCI review panels and is a current a member of the DHHS/NIH Panel on Antiretroviral Guidelines for Adults and Adolescents.

  • Anne Liu

    Anne Liu

    Clinical Associate Professor, Pediatrics - Immunology and Allergy
    Clinical Associate Professor, Medicine - Infectious Diseases
    Clinical Associate Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Liu is a board-certified, fellowship-trained specialist in allergy/immunology and infectious disease. She is also a clinical associate professor in the Department of Medicine, Division of Infectious Diseases and the Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology at Stanford University School of Medicine.

    Dr. Liu treats infections in patients with compromised immune systems, whether due to a primary immune deficiency or a condition like cancer or organ transplant. She helps patients to develop tolerance to medications they are allergic to so that they can receive the best, and sometimes the only, treatments available to them. She also treats allergies to antibiotics, aspirin, NSAIDs, chemotherapy, and more. She sees patients both long term and for urgent referrals, such as in cases of perioperative anaphylaxis. Dr. Liu also helps pediatric patients manage drug and food allergies.

    One of Dr. Liu’s areas of focus is helping patients with allergies to antibiotics determine when they have lost an allergy, what antibiotics they can tolerate, and when to induce tolerance to an antibiotic. This not only can benefit the patient, but also have a positive public health impact, as labeling patients with a penicillin allergy may negatively affect their care and increase use
    of broad-spectrum antibiotics.

    She collaborates closely with colleagues from other disciplines, including pulmonology, otolaryngology, oncology, cardiology, dermatology, anesthesiology, and surgery. Her key objective in working with referring physicians is to help them safely deliver the best care for their patients.

    For patients and families, Dr. Liu strives to help them navigate their care journey with as much ease and dignity as possible during what may be the most challenging time of their life. Her goal is to offer patients options, even when it may appear that they have no options left.

    Dr. Liu’s research interests include optimizing care of patients with antibiotic allergies, including through use of decision support tools.

    Dr. Liu has authored articles in the New England Journal of Medicine, Journal of Immunology, Journal of Allergy and Clinical Immunology in Practice, Clinical and Experimental Allergy, Mucosal Immunology, Diagnostic Microbiology and Infectious Disease, Science, and other publications. Dr. Liu authored the book chapter “Hypersensitivity Reactions to Monoclonal Antibodies” in Drug Allergy Testing.

    Dr. Liu is certified in infectious disease by the American Board of Internal Medicine and in allergy and immunology by the American Board of Allergy and Immunology. She is also a member of the American College of Physicians, Infectious Diseases Society of America, and American Academy of Allergy, Asthma, and Immunology.

    She has given presentations on antibiotic allergies, drug desensitization, and aspirin-exacerbated respiratory disease, among other topics. Dr. Liu’s honors include recognition from the American Academy of Asthma, Allergy, and Immunology, the American Medical Women’s Association, and the National Institutes of Health.

  • Nathan Lo

    Nathan Lo

    Assistant Professor of Medicine (Infectious Diseases)

    Current Research and Scholarly InterestsOur research laboratory is interested in studying the transmission of infectious diseases and impact of public health interventions with an ultimate goal of informing public health policy. We study a diverse set of pathogens including vaccine-preventable infections (including COVID-19) and neglected tropical diseases. Our group applies diverse computational methodologies, including tools of epidemiology, modeling, pathogen genomics, and policy analysis.

    A large emphasis of our work is translating scientific evidence into public health policy. Our track record includes multiple studies that have changed policy in the fields of neglected tropical diseases and COVID-19. We work closely with policy organizations like the World Health Organization and the California Department of Public Health.

    Our current research focuses on the following areas:
    (1) Vaccine-preventable infectious diseases (including COVID-19) in the United States, with a focus on studying vaccines and transmission dynamics
    (2) Public health strategies for control and elimination of globally important neglected infectious diseases, such as helminths infections (schistosomiasis, strongyloidiasis) and typhoid fever

    Hiring
    We are seeking to fill multiple research positions at all levels. Candidates interested in working on computational public health research related to infectious diseases with a strong quantitative background are highly encouraged to apply. If you an interested, please submit a cover letter, CV, and names of two references to Nathan.Lo@stanford.edu.

  • Stephen Luby

    Stephen Luby

    Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting pathways of infectious disease transmission in low income countries.